Cas:54576-13-5 dimethyl 3-methylhexanedioate manufacturer & supplier

Chemical Name:dimethyl 3-methylhexanedioate

CAS.NO:54576-13-5

Synonyms:3-Methyl-adipinsaeure-dimethylester;3-methyl-hexanedioic acid dimethyl ester;Hexanedioic acid,3-methyl-,dimethyl ester;(+-)-3-methyl-adipic acid dimethyl ester

Molecular Formula:C₉H₁₆O₄

Molecular Weight:188.22100

HS Code:2917190090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:52.60000

Exact Mass:188.10500

LogP:1.13880

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-Methyl-adipinsaeure-dimethylester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(+-)-3-methyl-adipic acid dimethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-methyl-hexanedioic acid dimethyl ester Use and application,(+-)-3-methyl-adipic acid dimethyl ester technical grade,usp/ep/jp grade.

Related News: Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. dimethyl 3-methylhexanedioate manufacturer Retrogenix��s proprietary cell microarray technology provides a fast, accurate and effective solution for determining the primary target and secondary target (off-target) activities of antibodies, proteins, cell therapies, small molecules and viruses. dimethyl 3-methylhexanedioate supplier The FDA said its decision allows for the J&J doses to be used in the United States or exported. T dimethyl 3-methylhexanedioate vendor Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. dimethyl 3-methylhexanedioate factory Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.